CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells.
Mijin ParkJin Hwa ChoByul MoonJeong-Hoon KimJung-Ae KimPublished in: Genes & genomics (2023)
Taken together, our findings suggest that CDK9 inhibitors are potent tools to target DKK1, which can suppress the metastatic progression of HCC.